MKI67 and breast cancer: In breast cancer, the hazard ratio per 2.7-fold increase in Ki-67 expression was 1.95 for recurrence-free survival.23 Applying the same methodology to our findings for ease of comparison, the hazard ratio for recurrence-free survival in endometrial cancer was 1.94 (95% CI 1.10–3.43).